Replimune REPL
NASDAQ REPL
$15.04 -0.25 (-1.64%)
As of: Sep 4, 2026 · 3:59 PM EDT

Replimune (REPL) Accumulated Depreciation (2018 - 2021)

Replimune (REPL) posted Accumulated Depreciation of $2.6 million for Q1 2021, up 22.93% sequentially from $2.2 million in Q4 2020, and up 182.6% YoY from $937000.0 in Q1 2020.

Analysis

Replimune (REPL) Accumulated Depreciation (2018 - 2021) Analysis & Trends

Replimune has reported Accumulated Depreciation for 4 years, with the latest figure at $2.6 million in Q1 2021.

  • Quarterly Accumulated Depreciation rose 182.6% year-over-year to $2.6 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $2.6 million (up 182.6% YoY) and the FY2021 annual result came in at $2.6 million, up 182.6% from the prior year.
  • Accumulated Depreciation advanced to $2.6 million in Q1 2021 per REPL's latest filing, from $2.2 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $2.6 million in Q1 2021 and troughed at $256000.0 in Q1 2018.
  • A 4-year average of $921846.2 and a median of $488000.0 in 2019 frame the typical range for Accumulated Depreciation.
  • The sharpest annual moves came in 2019 and 2020: Accumulated Depreciation soared 50.15% in 2019, then jumped 262.02% in 2020.
  • Over 4 years, Accumulated Depreciation stood at $362000.0 in 2018, then jumped by 64.36% to $595000.0 in 2019, then surged by 262.02% to $2.2 million in 2020, then rose by 22.93% to $2.6 million in 2021.
  • According to Business Quant data, Accumulated Depreciation over the past three periods registered $2.6 million, $2.2 million, and $1.8 million for Q1 2021, Q4 2020, and Q3 2020 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Replimune 1.46 Bn 1.46 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 2.65 Mn
Dec 31, 2020 2.15 Mn
Sep 30, 2020 1.75 Mn
Jun 30, 2020 1.33 Mn
Mar 31, 2020 937,000.00
Dec 31, 2019 595,000.00
Sep 30, 2019 488,000.00
Jun 30, 2019 446,000.00
Mar 31, 2019 404,000.00
Dec 31, 2018 362,000.00
Sep 30, 2018 325,000.00
Jun 30, 2018 289,000.00
Mar 31, 2018 256,000.00